Figure - available from: Evidence-based Complementary and Alternative Medicine
This content is subject to copyright. Terms and conditions apply.
Histopathological manifestations of the myocardium in each group of rats. Note: A is the sham group, B is the sepsis group, C is the low-dose Draba scabra group, D is the medium-dose Draba scabra group, and E is the high-dose Draba scabra group (HEX40).

Histopathological manifestations of the myocardium in each group of rats. Note: A is the sham group, B is the sepsis group, C is the low-dose Draba scabra group, D is the medium-dose Draba scabra group, and E is the high-dose Draba scabra group (HEX40).

Source publication
Article
Full-text available
Objective: The aim of this study was to observe the efficacy and mechanism of Draba scabra in sepsis myocarditis. Methods: The efficacy and pathways of action of Draba scabra on septic myocarditis were evaluated by making a rat model of sepsis with appendix perforation, using Draba scabra for pharmacological intervention, and measuring serum inf...